What is the restriction point?
Publication type: Journal Article
Publication date: 1995-01-01
scimago Q1
wos Q2
SJR: 2.780
CiteScore: 10.6
Impact factor: 4.3
ISSN: 09550674, 18790410
PubMed ID:
8608014
Cell Biology
Abstract
The restriction point (R) separates two functionally different parts of G1 in continuously cycling cells. G1-pm represents the postmitotic interval of G1 that lasts from mitosis to R. G1-ps represents the pre S phase interval of G1 that lasts from R to S. G1-pm is remarkably constant in length (its duration is about three hours) in the different cell types studied so far. G1-ps, however, varies considerably, indicating that entry into S is not directly followed after passage through R. Progression through G1-pm requires continuous stimulation by mitogenic signals (e.g. growth factors) and a high rate of protein synthesis. Interruption of the mitogenic signals or moderate inhibition of protein synthesis leads to a rapid exit from the cell cycle to G0 in normal (untransformed) cells. Upon restimulation with mitogenic signals, the cell returns to the same point in G1-pm from which it left the cell cycle. Thus the cell seems to have a memory for how far it has advanced through G1-pm, suggesting that a continuous structural alteration, for example chromatin decondensation, takes place in G1. The molecular background to transition from growth factor dependence in G1-pm to growth factor independence in G1-ps (a switch which represents commitment to a new cell cycle and passage through R) is still not fully understood. Cyclin-dependent kinase (cdk)-mediated hyperphosphorylation of the retinoblastoma protein (Rb), and concomitant liberation (and activation) of members of the E2F family of transcription factors, are probably important aspects of R control in normal cells. A key component here could be cdk2 activity which is controlled by cyclin E. When cdk2 activity starts to increase rapidly in G1, due to activation of a positive feedback loop, it reaches a critical level above which cdk inhibitors (CKIs) such as p21 and p27 are outweighed; the cell has then become independent of mitogenic and inhibitory signals and is committed to a new cell cycle. However, other components are probably also involved in R control. For instance, a 'cryptic' R (a G1-pm-like state) can be induced even in tumour cells that do not respond to growth factor starvation or protein synthesis inhibitors, and are therefore probably defective in the cdk-Rb-E2F pathway. Possibly, a certain degree of chromatin decondensation has to take place after mitosis in order to allow transcription of, for example, the cyclin E gene or other critical E2F targets. Although the molecular basis for restriction point control still remains unclear, we can expect rapid progress in this important field over the next few years.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Journal of Biological Chemistry
6 publications, 2.47%
|
|
|
Oncogene
6 publications, 2.47%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
6 publications, 2.47%
|
|
|
Cell
5 publications, 2.06%
|
|
|
Experimental Cell Research
5 publications, 2.06%
|
|
|
PLoS ONE
5 publications, 2.06%
|
|
|
Molecular and Cellular Biology
5 publications, 2.06%
|
|
|
Molecular Cell
3 publications, 1.23%
|
|
|
FASEB Journal
3 publications, 1.23%
|
|
|
Developmental Dynamics
3 publications, 1.23%
|
|
|
Methods in Molecular Biology
3 publications, 1.23%
|
|
|
Cell Cycle
3 publications, 1.23%
|
|
|
Progress in cell cycle research
3 publications, 1.23%
|
|
|
Current Opinion in Cell Biology
2 publications, 0.82%
|
|
|
Kidney International
2 publications, 0.82%
|
|
|
Journal of Investigative Dermatology Symposium Proceedings
2 publications, 0.82%
|
|
|
Endocrinology
2 publications, 0.82%
|
|
|
DNA and Cell Biology
2 publications, 0.82%
|
|
|
Frontiers in Cell and Developmental Biology
2 publications, 0.82%
|
|
|
Scientific Reports
2 publications, 0.82%
|
|
|
British Journal of Cancer
2 publications, 0.82%
|
|
|
Biochemical and Biophysical Research Communications
2 publications, 0.82%
|
|
|
PLoS Biology
2 publications, 0.82%
|
|
|
PLoS Computational Biology
2 publications, 0.82%
|
|
|
Biochimica et Biophysica Acta - Molecular Basis of Disease
2 publications, 0.82%
|
|
|
Free Radical Biology and Medicine
2 publications, 0.82%
|
|
|
Neuron
2 publications, 0.82%
|
|
|
International Journal of Cancer
2 publications, 0.82%
|
|
|
Cell Proliferation
2 publications, 0.82%
|
|
|
1
2
3
4
5
6
|
Publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
56 publications, 23.05%
|
|
|
Wiley
42 publications, 17.28%
|
|
|
Springer Nature
35 publications, 14.4%
|
|
|
Public Library of Science (PLoS)
9 publications, 3.7%
|
|
|
Taylor & Francis
9 publications, 3.7%
|
|
|
Frontiers Media S.A.
8 publications, 3.29%
|
|
|
Cold Spring Harbor Laboratory
7 publications, 2.88%
|
|
|
American Society for Biochemistry and Molecular Biology
6 publications, 2.47%
|
|
|
American Society for Microbiology
6 publications, 2.47%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
6 publications, 2.47%
|
|
|
MDPI
4 publications, 1.65%
|
|
|
Oxford University Press
4 publications, 1.65%
|
|
|
Mary Ann Liebert
3 publications, 1.23%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
3 publications, 1.23%
|
|
|
American Chemical Society (ACS)
3 publications, 1.23%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 0.82%
|
|
|
The Endocrine Society
2 publications, 0.82%
|
|
|
The Royal Society
2 publications, 0.82%
|
|
|
American Society of Hematology
2 publications, 0.82%
|
|
|
Rockefeller University Press
2 publications, 0.82%
|
|
|
American Society for Cell Biology (ASCB)
2 publications, 0.82%
|
|
|
IMR Press
2 publications, 0.82%
|
|
|
AIP Publishing
1 publication, 0.41%
|
|
|
The Company of Biologists
1 publication, 0.41%
|
|
|
CSIRO Publishing
1 publication, 0.41%
|
|
|
Portland Press
1 publication, 0.41%
|
|
|
SAGE
1 publication, 0.41%
|
|
|
European Society for Artificial Organs (ESAO)
1 publication, 0.41%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
243
Total citations:
243
Citations from 2024:
6
(2.47%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Zetterberg A., Larsson O., Wiman K. G. What is the restriction point? // Current Opinion in Cell Biology. 1995. Vol. 7. No. 6. pp. 835-842.
GOST all authors (up to 50)
Copy
Zetterberg A., Larsson O., Wiman K. G. What is the restriction point? // Current Opinion in Cell Biology. 1995. Vol. 7. No. 6. pp. 835-842.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/0955-0674(95)80067-0
UR - https://doi.org/10.1016/0955-0674(95)80067-0
TI - What is the restriction point?
T2 - Current Opinion in Cell Biology
AU - Zetterberg, Anders
AU - Larsson, Olle
AU - Wiman, K. G.
PY - 1995
DA - 1995/01/01
PB - Elsevier
SP - 835-842
IS - 6
VL - 7
PMID - 8608014
SN - 0955-0674
SN - 1879-0410
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{1995_Zetterberg,
author = {Anders Zetterberg and Olle Larsson and K. G. Wiman},
title = {What is the restriction point?},
journal = {Current Opinion in Cell Biology},
year = {1995},
volume = {7},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/0955-0674(95)80067-0},
number = {6},
pages = {835--842},
doi = {10.1016/0955-0674(95)80067-0}
}
Cite this
MLA
Copy
Zetterberg, Anders, et al. “What is the restriction point?.” Current Opinion in Cell Biology, vol. 7, no. 6, Jan. 1995, pp. 835-842. https://doi.org/10.1016/0955-0674(95)80067-0.